Chemical Structures Technical Specifications BPC-157 Component Technical Specifications TB-500 Component The combinations structural diversity BPC-157s compact proline-rich sequence providing gastric acid resistance, paired with TB-500s larger actin-binding domain creates a multi-faceted approach to tissue repair that addresses both localized and systemic healing requirements
01 Gastric Pentadecapeptide Synthetic 15-amino-acid peptide derived from human gastric juice protein 02 99% HPLC Purity Every batch verified via high-performance liquid chromatography 03 USA Tested & Verified Third-party analytical testing performed in USA laboratories RESEARCH BPC-157 Mechanism of Action in Research The BPC-157 mechanism of action has been a central focus of preclinical research for over two decades
The committee members who voted yes generally believed the risks to be minimal, while those who voted no tended to worry about safety risks and effectiveness, and expressed concern that adding the peptide to the compounding list would create a false impression that it has been evaluated with the same rigorous standards as an FDA-approved drug
Individual results vary, and NexLife does not guarantee weight loss, treatment success, clinical outcomes, prescription approval, medication eligibility, pharmacy availability, fulfillment timelines, or delivery outcomes
Research Focus : Safety & Metabolism (Non-Clinical) Title : Safety and Metabolism of AOD9604, a Novel Nutraceutical Ingredient for Improved Metabolic Health (J Endocrinol Metab, Vol 4, No 3, June 2014) Authors : Margret I
